Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIOVF | GMAB | GH | ||
| Company | Swedish Orphan Biovit Ord | Genmab A/S ADR | Guardant Health Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 47.4750 | 26.88 | 113.44 | ||
| High | 47.4750 | 27.19 | 121.01 | ||
| Low | 47.4750 | 26.63 | 111.20 | ||
| Latest | 47.4750 | 27.05 | 118.01 | ||
| Change | +0.1250 | -0.16 | +3.04 | ||
| % Change | +0.26% | -0.59% | +2.64% | ||
| Volume | 200 | 1,050,300 | 4,934,800 | ||
| 20-Day Average Volume | 455 | 2,184,940 | 2,166,185 | ||
| Previous Close | 47.3500 | 27.21 | 114.97 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 34.7033 | 26.74 | 94.75 | ||
| 20-Day Raw Stochastic | 100.00% | 58.17% | 92.86% | ||
| 20-Day Relative Strength | 73.93 | 49.35 | 71.14 | ||
| Weighted Alpha | N/A | +18.03 | +136.54 | ||
| Today's Opinion | N/A | 72% Sell | 56% Buy | ||
| Previous Opinion | N/A | 56% Sell | 56% Buy | ||
| Last Month's Opinion | N/A | 56% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +28.31% since 01/14/26 | +0.56% since 05/14/26 | +19.61% since 05/14/26 | ||
| Low | 39.8701 on 03/31/26 | 25.52 on 05/19/26 | 92.50 on 05/15/26 | ||
| High | 47.4750 on 05/05/26 | 27.36 on 05/20/26 | 121.01 on 05/21/26 | ||
| 1-Month | |||||
| %Chg | +19.07% since 03/31/26 | -0.04% since 04/21/26 | +30.60% since 04/21/26 | ||
| Low | 43.1500 on 04/27/26 | 25.34 on 05/08/26 | 79.01 on 04/30/26 | ||
| High | 47.4750 on 05/05/26 | 28.28 on 05/07/26 | 121.01 on 05/21/26 | ||
| 3-Month | |||||
| %Chg | +28.31% since 01/14/26 | -7.65% since 02/20/26 | +14.46% since 02/20/26 | ||
| Low | 39.8701 on 03/31/26 | 24.95 on 03/20/26 | 74.55 on 04/10/26 | ||
| High | 47.4750 on 05/05/26 | 29.85 on 03/02/26 | 121.01 on 05/21/26 | ||
| 6-Month | |||||
| %Chg | +36.11% since 11/04/25 | -11.17% since 11/21/25 | +11.94% since 11/21/25 | ||
| Low | 35.2500 on 12/03/25 | 24.95 on 03/20/26 | 74.55 on 04/10/26 | ||
| High | 47.4750 on 05/05/26 | 35.43 on 01/14/26 | 121.01 on 05/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 16,901,100 | 16,965,624 | 15,245,022 | ||
| Shares Outstanding, K | 356,000 | 623,507 | 132,600 | ||
| Annual Sales | 2,885,920,000 | 3,720,000,000 | 982,020,000 | ||
| Annual Net Income | 48,850,000 | 963,000,000 | -416,280,000 | ||
| Last Quarter Sales | 785,980,000 | 896,000,000 | 301,670,000 | ||
| Last Quarter Net Income | 144,200,000 | 53,000,000 | -112,080,000 | ||
| 60-Month Beta | 0.34 | 0.86 | 1.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.45 on 04/28/26 | 0.15 on 05/07/26 | -0.45 on 05/07/26 | ||
| Earnings Date | 07/15/26 | 08/06/26 | 07/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 24.53 | 18.47 | 0.00 | ||